Skip to main content
Erschienen in: Journal of the International AIDS Society 4/2010

Open Access 01.11.2010 | Poster presentation

Role of HCV infection in the development of carotid atherosclerosis in a cohort of HIV-infected patients

verfasst von: S Ferrara, A Tartaglia, T Santantonio, B Grisorio

Erschienen in: Journal of the International AIDS Society | Sonderheft 4/2010

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Background

HIV-infected patients have an increased risk of cardiovascular disease. Measurement of carotid artery intima-media-thickness (c-IMT) with colour-doppler-ultrasonography is a well-accepted, non-invasive method to assess carotid atherosclerosis.

Purpose of the study

To investigate whether HCV infection could be involved in the development of carotid atherosclerosis beside the well-known risk factors.

Patients and methods

In this cohort study, 322 consecutive HIV+ subjects were identified and enrolled between May 2009 and May 2010. A total of 153 patients were HIV/HCV co-infected, whereas 169 were HIV+ mono-infected; 237 patients were treated with highly active antiretroviral therapy (HAART), and 85 subjects were HAART-naïve. All patients underwent at least one c-IMT measurement by the same examiner; an IMT of >0.9 mm was considered pathological.

Results

Overall, 112/322 (35%) patients showed c-IMT >0.9. Table 1 shows the correlation between c-IMT and the following risk factors: age, cigarette smoking, intravenous drug use, CD4 cell count <200/mmc, CDC stage C of HIV infection, PI-based regimens and HCV co-infection. A significant statistical association between all considered factors and increased c-IMT was found. In particular, HCV co-infection showed a greater association in addition to older age, dyslipidemia, stage C of HIV infection.
Table 1
 
c-IMT<0.9
 
c-IMT> 0.9
  
 
n. 210
%
n. 112
%
p
age >40 years
121
57.6%
105
93.8%
<0.0001
cigarette smoking
42
20%
70
63%
0.03
IVDU
79
37.6%
56
50%
0.03
Cholesterolemia >200 mg/dL
50
23.8%
51
45.5%
0.0006
Triglyceridemia >170 mg/dL
58
27.6%
52
46.4%
0.0006
CDC Stage C
69
38.9%
68
60.7%
<0.0001
HAART - PI exposure
56
40.9%
81
59.1%
0.001
CD4 cell count <200/mmc
36
17.1%
36
32.1%
0.002
HCV co-infection
85
40.5%
68
60.7%
0.0005

Conclusions

In this cohort, several risk factors seem contribute to inflammatory damage and c-IMT development. Among them, HCV co-infection has been identified as a major determinant of carotid atherosclerosis. If the role of HCV infection will be confirmed in further studies, HIV-HCV co-infected patients should be strictly monitored for the vascular status.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Metadaten
Titel
Role of HCV infection in the development of carotid atherosclerosis in a cohort of HIV-infected patients
verfasst von
S Ferrara
A Tartaglia
T Santantonio
B Grisorio
Publikationsdatum
01.11.2010
Verlag
BioMed Central
Erschienen in
Journal of the International AIDS Society / Ausgabe Sonderheft 4/2010
Elektronische ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-13-S4-P204

Weitere Artikel der Sonderheft 4/2010

Journal of the International AIDS Society 4/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.